Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
VEGF
>>
Phase 1
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
ASKG712
/ Aosaikang Pharma, AffaMed Therap
JY028
(bevacizumab biosimilar) / Beijing Eastern Biotech
agerafenib
(RXDX-105) / Roche, Daiichi Sankyo
APL-102
/ Apollomics
ASP1948
/ Astellas
AUR-109
/ Orion Corp, Dr. Reddy’s
Alymsys
(bevacizumab-maly) / Amneal, Pharmaceutical Libbs, Grupo Insud, Nichi-Iko, Stada
HB-002
/ Zhejiang Huahai Pharma
OSI-930
/ Astellas
RPH-001
(bevacizumab biosimilar) / R-Pharm, Alphamab
SYHA1813
/ CSPC Pharma, Shanghai Inst. of Materia Medica
denfivontinib
(SKI-G-801) / Oscotec
kanitinib
(CX1003) / Konruns Pharma
lenvatinib gel suspension
(AIV007) / AiViva BioPharma
nintedanib inhaled
(AP02) / Avalyn Pharma
vesencumab
(MNRP1685A) / Roche
3D011
/ 3DMed
4SC 203
/ 4SC
AK-3008
(bevacizumab biosimilar) / Aosaikang Pharma, Anhui Anke Biotech
Affecizx
(hPV19) / Stainwei Biotech
Anbeisi
(bevacizumab biosimilar) / Sino Biopharm
AngioCal
(40 kDA PEGylated anticalin) / Pieris Pharmaceuticals
B1962
/ AP Biosciences
BD311
/ BDgene
CMAB818
(ranibizumab biosimilar) / 3SBio
CVX-241
/ Pfizer
CYC116
/ Cyclacel
DR30206
/ Huadong Medicine
ETN101
/ Etnova Therap
EVT801
/ Kazia
GZ402663
/ Sanofi, AGTC
HB002.1M
/ Zhejiang Huahai Pharma
HLX12
(ramucirumab biosimilar) / Fosun Pharma
IBI-324
/ Innovent Biologics
IBI-333
/ Innovent Biologics
ICP-033
/ InnoCare
IMM2510
/ ImmuneOnco Biopharma
JHL1149
(bevacizumab biosimilar) / Eden Biologics
JNJ-26483327
/ J&J
JS207
/ Shanghai Junshi Biosci
KDR2-2
/ Guangzhou HuiBoRui Biological
KPG-121
/ Kangpu Biopharma
LY3022856
/ Eli Lilly
LYN-00101
/ Lynkcell
MG-D-1509
/ Metagone Biotech
MSB0254
/ Transcenta
OB318
/ Microbio
PB101
/ Panolos Biosci
PF-337210
/ Pfizer
PM8003
/ Biotheus
1
2
»
